Sh.Ph. ERDES¹, T.V. DUBININA¹, S.А. LAPSHINA², L.I. MYASOUTOVA²

¹Nasonova Research Institute of Rheumatology RAMS, 34A Kashirskoye highway, Moscow, Russian Federation, 115522

²Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

Erdes Sh.Ph, D. Med. Sc., Professor, Deputy Director for Science, tel. (499)614-44-86, e-mail: omsi@irramn.ru

Dubinina T.V, Cand. Med. Sc., senior research scientist of laboratory of spondylarthritis, tel. (499) 614-44-76, e-mail: omsi@irramn.ru

Lapshina S.A, Cand. Med. Sc., Associate Professor of the Department of hospital therapy,

tel. (843) 237-34-83, e-mail: svetlanalapshina@mail.ru.

Myasoutova L.I, assistant of the Department of hospital therapy, tel. (843) 237-34-83, e-mail: myasoutova74@mail.ru.

Diagnosis of ankylosing spondylitis (AS) in actual practice is delayed by 7-8 years. This situation is connected with the scarcity and variability of clinical manifestations in the beginning of the disease, poor knowledge of disease symptoms by primary care physicians, late development of radiologic defined sakroiliitus — an important criteria for diagnosis. Use of magnetic resonance imaging (MRI) helps in diagnosis of AS in the early, pre-radiologic stages. At the beginning of the disease there is the appearance of the first clinical signs of AS, among which the main is inflammatory back pain by criteria of ASAS experts in 2009; peripheral arthritis, enthesitis, uveitis, psoriasis, internal lesions also happen. Educational programs for primary care physicians and performance of special diagnostic procedures for suspected AS can timely refer patients to a rheumatologist. Modified AS criteria can be used for diagnosis in the early stages of the disease.

Key words: ankylosing spondylitis, spondyloarthritis, early diagnosis.

REFERENCES

1. Folomeeva O.M., Galushko E.A., Erdes Sh.F. The prevalence of rheumatic diseases in populations of the adult population of Russia and the United States Scientific. Nauchno-prakticheskaya revmatologiya, 2008, no. 4, pp. 4-13 (in Russ.).
2. Volnukhin E.V., Galushko E.A., Bochkova A.G. et al. Clinical diversity of ankylosing spondylitis in actual practice rheumatologist in Russia (Part 1). Nauchno-prakticheskaya revmatologiya, 2012, no. 51(2), pp. 44-9 (in Russ.).
3. Feldtkeller E., Khan M.A., van der Heijde D. et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int, 2003, vol. 23, rr. 61-66.
4. Brandt H.C., Spiller I., Song I.H. et al. Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann Rheum Dis, 2007, vol. 66, rr. 1479-1484.
5. Poddubnyy D., Vahldiek J., Spiller I. et al. Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care. J Rheumatol, 2011, vol. 38, rr. 2452-2460.
6. Dubinina T.V., Erdes Sh.F. The reasons for late diagnosis of ankylosing spondylitis in general clinical practice. Nauchno-prakticheskaya revmatologiya, 2010, no. 2, pp. 43-50 (in Russ.).
7. Myasoutova L.I., Lapshina S.A., Vasil’ev A.G., Salikhov I.G. Diagnosis and clinical characteristics of ankylosing spondylitis according to city rheumatologic center of Kazan. Nauchno-prakticheskaya revmatologiya, 2012, no. 1, pp. 38-41 (in Russ.).
8. Lapshina S.A., Myasoutova L.I., Mukhina R.G., Salikhov I.G. The effectiveness of educational programs for early detection of ankylosing spondylitis for the primary care physicians in Kazan. Nauchno-prakticheskaya revmatologiya, 2014, no. 2, pp. 183-187 (in Russ.).
9. Van der Linden S., Valkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum, 1984, vol. 27, rr. 361-8.
10. Mau W., Zeidler H., Mau R. et al. Clinical features and prognosis of patients with possible ankylosing spondylitis: results of a 10-year followup. J Rheumatol, 1988, vol. 15, rr. 1109-14.
11. Oostveen J., Prevo R., den Boer J., van de Laar M. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography: a prospective, longitudinal study. J Rheumatol, 1999, vol. 26, rr. 1953-8.
12. Rudwaleit M., Jurik A.G., Hermann K.-G.A., Landewe R. van der Heijde D., Baraliakos X., Marzo-Ortega H., Ostergaard M., Braun J., Sieper J. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis, 2009, vol. 68, rr. 1520-1527.
13. Ahlstrom H., Feltelius N., Nyman R., Hallgren R. Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis Rheum, 1990, vol. 33, rr. 1763-9.
14. Braun J., Bollow M., Eggens U. et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum, 1994, 37, rr. 1039-45.
15. Rudwaleit M., Khan M.A., Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum, 2005, vol. 52, rr. 1000-1008.
16. Van der Heijde D., Rudwaleit M., Landewé R., Sieper J. Justification for including MRi as a tool in the diagnosis of axial SpA. Nat. Rev. Rheumatol, 2010, vol. 6, rr. 670-672.
17. Bochkova A.G., Levshakova A.V., Bunchuk N.V. Early diagnosis of ankylosing pondilita: checking axial spondyloarthritis criteria proposed by an international working group for the study of ankylosing spondylitis (ASAS). Nauchno-prakticheskaya revmatologiya, 2010, no. 2, pp. 36-43 (in Russ.).
18. Gong Y., Zheng N., Chen S. et al. Ten Years’ Experience With Needle Biopsy in the Early Diagnosis of Sacroiliitis. Arth Rheum, 2012, vol. 64, rr. 1399-1406.
19. Rudwaleit M., Haibel H., Baraliakos X. et al. The early disease stage in axial spondylarthritis. Results from the German spondyloarthritis inception cohort. Arthritis Rheum, 2009, vol. 60(3), rr. 717-727.
20. Rudwaleit M., Claudepierre P., Wordsworth P. et al. Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis. J. Rheumatol, 2009, vol. 36(4), rr. 801-808.
21. Vastesaeger N., van der Heijde D., Inman R.D. et al. Predicting the outcome of ankylosing spondylitis therapy. Ann. Rheum. Dis, 2011, vol. 70(6), rr. 973-981.
22. Dubinina T.V., Galushko E.A., Erdes Sh.F. The frequency and nature of pain in the lower back among outpatients in Moscow. Message 2. Nauchno-prakticheskaya revmatologiya, 2008, no. 2, pp. 13-16 (in Russ.).
23. Sieper J., van der Heijde D., Landewe R. et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis International Society (ASAS). Ann. Rheum. Dis, 2009, vol. 68, pp. 784-88.
24. Poddubnyy D. Axial spondyloarthritis: is there a treatment of choice? Ther Adv Musculoskel Dis, 2013, vol. 5(1), rr. 45-54.
25. Rudwaleit M., van der Heijde D., Landewe R., Akkoc N., Brandt J., Chou C. et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis, 2011, vol. 70, rr. 25-31.
26. Braun J., Pincus T. Mortality. Course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol, Nov-Dec 2002, 20 (6 suppl. 28), rr. 16-22.
27. Schlosstein L., Terasaki P.I., Bluestone R., Pearson C.M. High association of an HL-A antigen W27 with ankylosing spondylitis. New Engl. J. Med, 1973, vol. 288, rr. 704-706.
28. Smith J.A., Märker-Hermann E., Colbert R.A. Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol, 2006, Jun, vol. 20(3), rr. 571-91.
29. Van der Linden S.M., Valkenburg H.A., Cats A. Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum, 1984, vol. 27, rr. 361-8.
30. Erdes Sh.F., Bochkova A.G., Dubinina T.V., Rumyantseva O.A., Smirnov A.V. Early diagnosis of ankylosing spondylitis. Nauchno-prakticheskaya revmatologiya, 2013, no. 4, pp. 365-67 (in Russ.).
31. Sieper J., Rudwaleit M., Baraliakos X. et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis, 2009, vol. 68, rr. ii1-ii44.
32. Haibel H., Heldmann F., Listing J. et al. Long-term efficacy of adalimumab after drug withdrawal and retreatment of flare patients in active non-radiographic, axial spondyloarthritis. Arthritis Rheum, DOI 10. 1002\art 38014.
33. Sieper J., Lenaerts J., Wollenhaupt J. et al. Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Published Online First: doi:10.1136/annrheumdis-2012-203201.
34. Song I.-H., Hermann K.G., Haibel H. et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active infl ammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis, 2011, vol. 70, rr. 590-596.